Recombinant GlyA from B. amyloliquefaciens is engineered with a His tag for purification, expressed in Saccharomyces cerevisiae or Escherichia coli systems . Key features include:
The glyA gene (UniProt ID: A0RLA3) encodes a 415-residue protein conserved across Bacillus species, with high sequence similarity to homologs in B. subtilis and B. stearothermophilus .
GlyA is essential for:
Folate Metabolism: Supplies one-carbon units for nucleotide and methionine biosynthesis .
Amino Acid Homeostasis: Balances serine/glycine pools and contributes to D-alanine synthesis in species lacking dedicated alanine racemases .
Stress Adaptation: Linked to biofilm regulation via modulation of S-adenosylmethionine (SAM) and cyclic-di-GMP levels in related Bacillus species .
Metabolic Engineering: CRISPR/Cas9n systems enable efficient glyA knockout or overexpression in B. amyloliquefaciens to optimize secondary metabolite production .
Enzyme Production: Recombinant GlyA is utilized in high-throughput assays for folate pathway analysis and inhibitor screening .
Substrate Specificity: GlyA from B. amyloliquefaciens exhibits broad specificity, catalyzing serine/glycine interconversion, alanine racemization, and threonine cleavage .
Inhibitor Sensitivity: Activity is suppressed by D-cycloserine, a D-Ala analog, highlighting its role in peptidoglycan precursor synthesis .
Thermostability: Retains >80% activity after 1 hour at 50°C, suitable for industrial processes .
While recombinant GlyA is robustly produced, optimizing its catalytic efficiency for non-natural substrates (e.g., D-serine) remains a focus. Advances in B. amyloliquefaciens genetic toolkits, such as bicistronic vectors and promoter engineering, are expected to enhance yields and application scope .
KEGG: bay:RBAM_034060